ICON plc, (NASDAQ: ICLR), a world-leading clinical research organization powered by healthcare intelligence, today announced its financial guidance for the year ending December 31, 2025.

The revised target comes in response to ICON's 2025 guidance, which Windley noted as being softer than expected. According to InvestingPro data, ICON's stock has experienced a significant 8.71% ...

(RTTNews) - ICON Plc (ICLR), healthcare intelligence and clinical research company, on Tuesday reaffirmed its annual guidance. In addition, the firm has initiated outlook for the full-year 2025.